ERNA vs PAYC · P/E 0.0, rev $582.0K vs P/E 33, rev $1.88B
Eterna Therapeutics Inc (ERNA) versus Paycom Soft (PAYC) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Paycom Soft (PAYC) is a software - application company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported PAYC revenue for 2024-12-31 was $1.88B. Net income was $502.0M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Not investment advice. Open the ERNA and PAYC stock pages for the full models.
Not investment advice.